Could a simple salt swap lower blood pressure in kidney transplant patients?
NCT ID NCT07178964
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether using a potassium-enriched salt substitute (75% regular salt, 25% potassium chloride) instead of regular table salt can help control blood pressure in kidney transplant recipients. About 80 participants will use either the special salt or regular salt at home for 12 weeks. The main goal is to see if blood pressure improves without causing dangerously high potassium levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- potassium-enriched salt substitute (25% potassium chloride, 75% sodium chloride)
- What this could lead to
- If it works, this could offer a simple dietary swap to help kidney transplant patients better control their blood pressure without extra medication.
- What could go wrong
- This is a small, early-stage trial with only 80 participants, so results may not apply broadly. There is a risk of dangerously high potassium levels (hyperkalemia) in some patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION ARTERIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the choice of anesthesia quiet the Body's surgical stress response?
- A simple blood test could spot kidney transplant rejection early
- Can your gut bacteria change how transplant drugs work?
- Zapping kidney nerves may tame both hypertension and anxiety
- Blood test may take the guesswork out of transplant drug dosing
- Immunotherapy may treat skin cancer in kidney transplant patients without rejection